Headshot of Chris Laing, Director of UCLPartners

Dr Chris Laing

Chief Executive Officer

Dr Chris Laing joined UCLPartners in October 2021, initially as the Director of Academic Health Science Network and National Director of the NHS Innovation Accelerator, before being appointed as UCLPartners Chief Executive Officer in February 2022. He has previously worked with UCLPartners, clinically leading its Patient Safety Acute Kidney Injury Improvement Collaborative from 2014-2016.

Chris undertook specialist training in nephrology, critical care and internal medicine, and continues to practise as a consultant nephrologist at University College London and Royal Free Hospitals, where he is also Honorary Associate Professor of Nephrology at the UCL Centre for Nephrology. He has remained active in research through clinical trials, health services research and the use of artificial intelligence in predicting acute renal disease. He has a strong interest in digital health, technology and data science and was previously a senior clinical advisor to DeepMind Health and Google Health.

Chris co-founded and chaired London Acute Kidney Injury (AKI) Network and has advised NICE and HQUIP in addition to being a member of the AKI National programme board. He is also a fellow of the Royal College of Physicians.

View the UCLPartners website.